HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

reptimed

produced in bone marrow by CD31 myeloid progenitors

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - reptimed: 2

Experts

1.	Chin, J: 1 article (01/2000)
2.	Howson-Jan, K: 1 article (01/2000)
3.	Ichim, T E: 1 article (01/2000)
4.	Kadhim, S A: 1 article (01/2000)
5.	Khandaker, M H: 1 article (01/2000)
6.	Singhal, S K: 1 article (01/2000)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2000 - "The corresponding histological examination of the whole mount bladder sections revealed similar inhibitory effects of Reptimed with respect to the topography and depth of intravesical tumor involvement. " 01/01/2000 - "Intravesicular and intraperitoneal administration of Reptimed concurrently with and following transurethral tumor cell implantation was performed and MBT-2 tumor response was assessed at several time points post tumor implant. " 01/01/2000 - "These studies demonstrate the anti-tumor effect of Reptimed and highlight its importance as a potential therapy for cancer." 01/01/2000 - "Serial MRI scans of Reptimed-treated mice at days 14 to 33 post tumor transplant revealed significant inhibition of bladder tumor growth with no significant tumor growth observed by MRI on day 33 post-implant. "
2.	Myeloid Leukemia (Leukemia, Myelocytic) 02/01/1997 - "Reptimed inhibited growth of granulocyte-macrophage and macrophage colonies as well as proliferation of several myeloid leukemia cell lines. " 02/01/1997 - "Suppression of myelopoiesis and myeloid leukemia cell line proliferation by a novel bone marrow-derived factor, reptimed."
3.	Urinary Bladder Neoplasms (Bladder Cancer) 01/01/2000 - "Prevention of bladder tumor formation in mice by a novel bone marrow-derived factor, reptimed." 01/01/2000 - "Serial MRI scans of Reptimed-treated mice at days 14 to 33 post tumor transplant revealed significant inhibition of bladder tumor growth with no significant tumor growth observed by MRI on day 33 post-implant. "

Related Therapies and Procedures

1.	Therapeutics